Trade Summary

2 days ago, Townson Sharon, serving as Chief Scientific Officer at Monte Rosa Therapeutics, Inc. (GLUE), sold 3,000 shares at $19.00 per share, for a total transaction value of $57,000.00. Following this transaction, Townson Sharon now holds 67,845 shares of GLUE.

This sale represents a 4.23% decrease in Townson Sharon's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, June 17, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 18, 2026 at 4:05 PM ET, 1 day after the trade was made.

Monte Rosa Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.